Pharmacist-delivered smoking cessation program for low-income patients
Determining the Feasibility of Delivering VergeRx to Smokers Through Pharmacies in Federally Qualified Health Centers Regardless of Readiness to Quit
This study tests whether a smoking cessation program led by pharmacists can help low-income smokers in community health centers quit smoking more effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Virginia Academic / other |
| Locations | 1 site (Charlottesville, Virginia) |
| Trial ID | NCT06161675 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of a pharmacist-delivered smoking cessation intervention at Federally Qualified Health Centers (FQHCs) targeting low-income smokers. The intervention includes medication management for nicotine replacement therapy to improve adherence among patients who smoke. The study aims to identify barriers and facilitators to implementing this program in FQHCs, which serve a population that is less likely to seek traditional cessation treatments. By leveraging community health resources, the study seeks to enhance smoking cessation efforts in rural Appalachia.
Who should consider this trial
Good fit: Ideal candidates are low-income adults aged 18 and older who smoke at least 5 cigarettes per day and are patients at participating FQHCs.
Not a fit: Patients who are pregnant, planning to become pregnant, or have medical contraindications to nicotine replacement therapy will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve smoking cessation rates among low-income individuals, leading to better health outcomes.
How similar studies have performed: Other studies have shown success with pharmacist-led interventions for smoking cessation, indicating a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient at participating Federally Qualified Health Center * ≥18 years of age * able to read, speak, and understand English * report smoking ≥5 cigarettes per day for the past 6 months * own a cell phone * be willing and able to use NRT in the form of patch or lozenge * not be pregnant or planning to be pregnant in the next 6 months Exclusion Criteria: * have a medical contraindication to NRT (e.g., past 30 days, heart attack or stroke; past 6 months, serious or worsening angina, very rapid or irregular heartbeat requiring medication)
Where this trial is running
Charlottesville, Virginia
- University of Virginia — Charlottesville, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Melissa A Little, PhD,MPH — University of Virginia
- Study coordinator: Dylan Allanson, MPH, RD
- Email: da4ac@virginia.edu
- Phone: 4342430424
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.